Vir Biotechnology, Inc. Public Float
Vir Biotechnology, Inc. (VIR) had Public Float of $689.20 million as of 2025-06-30, per its 10-K filed 2026-02-23.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-23
- 2025-06-30: Entity Public Float $689.20M.
- 2024-06-30: Entity Public Float $745.60M.
- 2023-06-30: Entity Public Float $1.80B.
- 2022-06-30: Entity Public Float $2.00B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $689.20M 10-K · filed 2026-02-23 |
| 2024-06-30 | $745.60M 10-K · filed 2025-02-27 |
| 2023-06-30 | $1.80B 10-K · filed 2024-02-26 |
| 2022-06-30 | $2.00B 10-K · filed 2023-02-28 |
| 2021-06-30 | $2.70B 10-K · filed 2022-02-28 |
| 2020-06-30 | $2.30B 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |